Iodine tre­at­ment in vi­tre­ous de­ge­ne­ra­tion

Krystyna Raczyńska; Witold Kokot; Ja­ro­sła­wa Kraj­ka­-La­uer; Barbara Iwaszkiewicz-Bilikiewicz

eISSN: 2719-3209
ISSN: 0023-2157

Klinika Oczna / Acta Ophthalmologica Polonica Supplement

Current supplement Archive Acta Ophthalmologica Polonica

3/2004
vol. 106

Send email

Copy url:

abstract:

Original paper

Iodine treatment in vitreous degeneration

Krystyna Raczyńska

¹

,

Witold Kokot

¹

,

Jarosława Krajka-Lauer

¹

,

Barbara Iwaszkiewicz-Bilikiewicz

¹

Z Katedry i Kliniki Chorób Oczu Akademii Medycznej w Gdańsku

KLINIKA OCZNA 2004, Supl. 3: S517–S520

Online publish date: 2022/12/29

View full text Get citation

Purpose
We present our result of topical administration of iodine in group of patients with corpus vitreous degeneration.

Material and methods
Corpus vitreous degeneration was studied in 360 patients (660 eyes), 184 male and 176 female. Treatment last form 6 to 12 month. We administrate iodine 3-4 times a day as an eye drops. The untreated control group consist of 110 person (204 eyes) 80 male and 50 female with similar corpus vitreous degeneration.

Results
The results are discussed in relation to our own vitreous degeneration scale. We come to a conclusion that topical administration of iodine reduce corpus vitreous degeneration.

keywords:

Iodine tre­at­ment in vi­tre­ous de­ge­ne­ra­tion

Krystyna Raczyńska 1 , Witold Kokot 1 , Ja­ro­sła­wa Kraj­ka­-La­uer 1 , Barbara Iwaszkiewicz-Bilikiewicz 1

iodine treatment, vitreolent, corpus vitreous degeneration

Iodine treatment in vitreous degeneration

Krystyna Raczyńska

¹

,

Witold Kokot

¹

,

Jarosława Krajka-Lauer

¹

,

Barbara Iwaszkiewicz-Bilikiewicz

¹